期刊文献+

宫颈鳞癌组织中Maspin、UPA和MMP9的表达及其意义 被引量:2

下载PDF
导出
摘要 目的观察Maspin、尿激酶型纤溶酶原激活物(UPA)、基质金属蛋白酶9(MMP9)在宫颈鳞癌组织中的表达,探讨其与宫颈鳞癌临床病理特征的关系及意义。方法运用免疫组织化学Envision二步法检测Maspin、UPA、MMP9在正常宫颈组织、C1N和宫颈鳞癌组织的表达情况,并进行统计学分析。结果宫颈鳞癌组织中Maspin的表达率为50%,明显低于正常组、CIN组(P<0.01);UPA、MMP9在宫颈鳞癌中表达率分别为66.3%、61.6%,明显高于正常组、C1N组(P<0.01);Maspin、UPA、MMP9与宫颈鳞癌的临床分期、浸润深度和淋巴结转移有关(P<0.05、P<0.01);Maspin与UPA、MMP9在宫颈鳞癌中表达呈负相关(P<0.01),UPA与MMP9间的表达呈正相关(P<0.01)。结论Maspin在宫颈鳞癌中表达下调,UPA、MMP9呈过表达,在宫颈鳞癌的浸润和转移中起重要作用,可作为反映宫颈癌生物学行为的有效指标。
机构地区 湖州市中心医院
出处 《浙江实用医学》 2008年第6期391-394,共4页 Zhejiang Practical Medicine
  • 相关文献

参考文献10

  • 1Zou Z, Anisowicz A, Hendrix M J,et al. Maspin,a serpin with tumorsuppressing activity in human mammary epithelial cells. Science, 1994, 263:526
  • 2Zheng H, Tsuneyama K, Koichi T, et al. Paradoxical expression of maspin in gastric carcinomas:correlation with carcinogenesis and ptogression. Human pathology,2007,38(8): 1248
  • 3Shi H Y, Zhang W, Liang R, et al. Modeling human breast cancer metastasis in mice: maspin as a paradigm. Histol Histopathol, 2003, 18 (1) :201
  • 4Herzog T J, New approaches for the rnanagemmt of cervical cancer. Gyneel Oncol, 2003,90(3) : 322
  • 5丁耘峰,冯一中,平金良,王晓红,李锋.Maspin在乳腺癌组织中的表达及临床病理意义[J].苏州大学学报(医学版),2007,27(3):396-398. 被引量:5
  • 6Kindzelskii A I, Amhad I, Keiier D, et al. Pericellular peoteolysis by leukocytes and tumor cells on substates focal activation and the role of urokinase- type plasminogen activator. Histochem Cell Biol, 2004, 121 (4) :299
  • 7Davidson B, Goldberg I, Kopolovie J, et al. Expression of matrix metalloproteinase - 9 in squamous cell carcinoma of the uterine cervix - clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gyneccl Oncol, 1999,72(3) :380
  • 8Xu C, Quddus M R, Sung C J, et al. Maspin expression in CIN 3, microinvasive squamons cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix. Mod Pathol, 21305,18(8): 1102
  • 9Biliran H Jr, Sheng S. Pleiotrophic inhibition of pericellular urokinase - type plasminogen activator system by endogenous tumor suppressive Maspin. Cancer Res, 2001, 61:8676
  • 10Fesmccia C, Angelucci A, Gravina G, et al. Bombesin - dependent pro -MMP9 activation in prostatic cancer cells requires betal integrin engagement. Ext Cell Res,2002,28(1)1

二级参考文献11

  • 1Zou Z,Anisowicz A,Hendrix MJ,et al.Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells[J].Science,1994,263(5146):526-529.
  • 2Sheng S,Carey J,Seftor EA,et al.Maspin acts at the cell membrance to inhibit invasion and motility of mammary and prostatic cancer cells[J].Proe Natl Acad Sci USA,1996,93(21):11669-11674.
  • 3Luppi M,Morselli M,Bandieri E,et al.Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene[J].Ann oncol,1996,7(6):619-624.
  • 4Maass N,Hojo T,Rosel F,et al.Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant[J].Clin Biochem,2001,34(4):303-307.
  • 5Maass N,Nagasaki K,Ziebart M,et al.Expression and regulation of tunlor suppressor gene maspin in breast cancer[J].Clin Breast Cancer,2002.3(4):281-287.
  • 6Zhang W,Zhang M.Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in varioLis tumors[J].Oncol,2002,20(6):1145-1150.
  • 7Biliran H Jr,Sheng S.Pleiotrophic inhibition of pericdlular urokinase-type plasminogen activator system by andogenous tumor suppressive maspin[J].Cancer Res,2001,61(24):8676-8682.
  • 8Liu J,Yin S,Reddy N,et al.Bax mediates the apoptosis-sensitizing effect of maspin[J].Cancer Res,2004,10(5):634-637.
  • 9Zhang M,Volpert O,Shi YH,et al.Maspin is an angiogenesis inhibitor[J].Nat Med,2000,6(2):196-199.
  • 10邵志敏,沈镇宙.乳腺肌上皮细胞抑制乳腺癌细胞体外浸润能力的研究[J].中华医学杂志,1999,79(3):214-216. 被引量:7

共引文献4

同被引文献37

  • 1Rabbani SA,Masar AP.The role of the plasminogen activation system in angiogenesis and metastasis.S u rg Oncol Clin N Am,2001,10(2):393-415.
  • 2Gandolfo GM,Conti L,Vercillo M,et al.Fibrinolysis c omponents as prognosticmarkers in breast cancer and c olorectal carcinoma.Anticancer Res,1996,16(4B):2155-2159.
  • 3Hoyer-Hansen C,Ploug M,Behrendt N,et al.Cell-surface acceleration of urokinase catalyzed receptor cleavage.Eur J Biochem,1997,243(1-2):21-26.
  • 4Duffy MJ,Maguim TM,McDermott EW,et a l.Urokinase plasminogen activator:A prognosticmarker in multiple types of cancer.J Surg Oncol,1999,71(2):130-135.
  • 5Behrendt N,Plouy M,Patthy L,et al.The ligand binding domain of the cell surface receptor for urokinase-type plasminogen activator.Biol Chem,1991,266(12):7842-7847.
  • 6Wei Y,Waltz DA,Rao N,et al.Identification of the urokinas e receptor as adhesion receptor for vitronectin.J Biol Chem,1999,269(51):32380-32388.
  • 7Kushlinskii NE,Gershtein ES,Kazantseva IA,et al.Plasminogen activators of urokinase and tissue types and their inhibitor(PAI-1)in c ytosol fraction in thyroid diseases.Vestn Ross Akad Med Nauk,2001,(5):32-34.
  • 8Baker EA,Bergin FG,Leaper DJ.Plasminogen activator system,vas cular en dothelial growth factor,and colorectal cancer progression.Clin Pathol Mol Pathol,2000,53(6):307-312.
  • 9Andreasen PA,Egelund R,Petersen HH.The plasminogen activator system in tumor growth,invasion,and metastasis.Cell Mol Life Sei,2000,57(1):25-40.
  • 10Dubuisson L,Monvoisin A,Nielsen BS,et al.Expression and cellular localization of the ur okinase-type plasminogen activator and its receptor in human hepatocelular carcinoma.J Pathol,2000,190(2):190-195.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部